Intradialytic hypotension and cardiac remodeling: A vicious cycle

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Chao, Chia Ter ^a,b   Huang, Jenq Wen ^a   Yen, Chung Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CARNITINE; IRON; VASOPRESSIN; VITAMIN D;

CARDIOVASCULAR DISEASE; CORONARY ARTERY; DRUG EFFICACY; DRUG INFUSION; END STAGE RENAL DISEASE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HEART VENTRICLE REMODELING; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; HYPOTENSION; INTRADIALYTIC HYPOTENSION; IRON THERAPY; NUTRITIONAL DEFICIENCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; STUNNED HEART MUSCLE; ULTRAFILTRATION; ADVERSE EFFECTS; BIOLOGICAL MODEL; CHRONIC KIDNEY FAILURE; COMPLICATION; PATHOLOGY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY;

HUMANS; HYPERTROPHY, LEFT VENTRICULAR; HYPOTENSION; KIDNEY FAILURE, CHRONIC; MODELS, BIOLOGICAL; RENAL DIALYSIS; VENTRICULAR REMODELING;

EID: 84947648742     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/724147     Document Type: Review

References (64)

1. K/DOQIWorkgroup, "K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients," American Journal of Kidney Disease, vol. 45, no. 4, supplement 3, pp. S1-S153, 2005.
2. F. M. Van Der Sande, J. P. Kooman, and K. M. L. Leunissen, "Intradialytic hypotension-new concepts on an old problem," Nephrology Dialysis Transplantation, vol. 15, no. 11, pp. 1746-1748, 2000.
3. J. T. Daugirdas, "Pathophysiology of dialysis hypotension: an update," American Journal of Kidney Diseases, vol. 38, no. 4, pp. S11-S17, 2001.
4. T. Shoji, Y. Tsubakihara, M. Fujii, and E. Imai, "Hemodialysisassociated hypotension as an independent risk factor for twoyear mortality in hemodialysis patients," Kidney International, vol. 66, no. 3, pp. 1212-1220, 2004.
5. J. K. Inrig, E. Z. Oddone, V. Hasselblad et al., "Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients," Kidney International, vol. 71, no. 5, pp. 454-461, 2007.
6. C. Calvo, S. Maule, F. Mecca, R. Quadri, G. Martina, and P. Cavallo Perin, "The influence of autonomic neuropathy on hypotension during hemodialysis," Clinical Autonomic Research, vol. 12, no. 2, pp. 84-87, 2002.
7. M. Koremoto, N. Takahara, M. Takahashi et al., "Improvement of intradialytic hypotension in diabetic hemodialysis patients using vitamin E-bonded polysulfone membrane dialyzers," Artificial Organs, vol. 36, no. 10, pp. 901-910, 2012.
8. C.-T. Chao, Y.-F. Lin, H.-B. Tsai, V.-C. Wu, and W.-J. Ko, "Acute kidney injury network staging in geriatric postoperative acute kidney injury patients: shortcomings and improvements," Journal of the American College of Surgeons, vol. 217, no. 2, pp. 240-250, 2013.
9. A. Lacquaniti, D. Bolignano, S. Campo et al., "Malnutrition in the elderly patient on dialysis," Renal Failure, vol. 31, no. 3, pp. 239-245, 2009.
10. J. T. Daugirdas, "Dialysis hypotension: a hemodynamic analysis," Kidney International, vol. 39, no. 2, pp. 233-246, 1991.
11. R.N. Foley, P. S. Parfrey, G. M. Kent, J.D. Harnett, D. C. Murray, and P. E. Barre, "Long-term evolution of cardiomyopathy in dialysis patients," Kidney International, vol. 54, no. 5, pp. 1720-1725, 1998.
12. E. Paoletti, D. Bellino, P. Cassottana, D. Rolla, and G. Cannella, "Left ventricular hypertrophy in nondiabetic predialysis CKD," American Journal of Kidney Diseases, vol. 46, no. 2, pp. 320-327, 2005.
13. R. N. Foley, P. S. Parfrey, J. D. Harnett et al., "Clinical and echocardiographic disease in patients starting end-stage renal disease therapy," Kidney International, vol. 47, no. 1, pp. 186-192, 1995.
14. R. N. Foley, P. S. Parfrey, and M. J. Sarnak, "Clinical epidemiology of cardiovascular disease in chronic renal disease," The AmericanJournal of KidneyDiseases, vol. 32, pp. S112-S119, 1998.
15. D. Levy, K.M. Anderson, D. D. Savage, W.B. Kannel, J. C. Christiansen, and W. P. Castelli, "Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham heart study," Annals of Internal Medicine, vol. 108, no. 1, pp. 7-13, 1988.
16. R. J. Glassock, R. Pecoits-Filho, and S. H. Barberato, "Left ventricular mass in chronic kidney disease and ESRD," Clinical Journal of the American Society of Nephrology, vol. 4, no. 1, pp. S79-S91, 2009.
17. M. Brahimi, M. Dahan, H. Dabiré, and B. I. Levy, "Impact of pulse pressure on degree of cardiac hypertrophy in patientswith chronic uraemia," Journal of Hypertension, vol. 18, no. 11, pp. 1645-1650, 2000.
18. C. Zoccali, F. A. Benedetto, F. Mallamaci et al., "Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis," Journal of theAmerican Society of Nephrology, vol. 12, no. 12, pp. 2768-2774, 2001.
19. C. Zoccali, F. A. Benedetto, F. Mallamaci et al., "Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression," Kidney International, vol. 65, no. 4, pp. 1492-1498, 2004.
20. G. M. London, B. Pannier, A. P. Guerin et al., "Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study," Journal of the American Society of Nephrology, vol. 12, no. 12, pp. 2759-2767, 2001.
21. F. O. B. Bonato, M. M. Lemos, J. L. Cassiolato, and M. E. F. Canziani, "Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients," PLoS ONE, vol. 8, no. 6, Article ID e66036, 2013.
22. P. M. Okin, C. N. Bang, K. Wachtell et al., "Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy," Circulation: Arrhythmia and Electrophysiology, vol. 6, no. 2, pp. 243-251, 2013.
23. J. O. Burton, S. Korsheed, B. J. Grundy, and C. W. McIntyre, "Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias," Renal Failure, vol. 30, no. 7, pp. 701-709, 2008.
24. C.-T. Chao, C.-C. Hou, V.-C. Wu et al., "The impact of dialysis- requiring acute kidney injury on long-term prognosis of patients requiring prolonged mechanical ventilation: nationwide population-based study," PLoS ONE, vol. 7, no. 12, Article ID e50675, 2012.
25. J. J. Mourad, B. Pannier, J. Blacher et al., "Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension," Kidney International, vol. 59, no. 5, pp. 1834-1841, 2001.
26. H. Miyoshi, Y. Oishi, Y. Mizuguchi et al., "Early predictors of alterations in left atrial structure and function related to left ventricular dysfunction in asymptomatic patients with hypertension," Journal of the American Society of Hypertension, vol. 7, no. 3, pp. 206-215, 2013.
27. T. S. M. Tsang, M. E. Barnes, B. J. Gersh, K. R. Bailey, and J. B. Seward, "Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden,"American Journal of Cardiology, vol. 90, no. 12, pp. 1284-1289, 2002.
28. F. M. Fouad, J. M. Slominski, and R. C. Tarazi, "Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function," Journal of the American College of Cardiology, vol. 3, no. 6, pp. 1500-1506, 1984.
29. S. H. Barberato and R. Pecoits Filho, "Valor prognóstico do índice do volume do átrio esquerdo em pacientes em hemodi álise," Arquivos Brasileiros de Cardiologia, vol. 88, pp. 643-650, 2007.
30. S. H. Barberato, M. Misocami, and R. Pecoits-Filho, "Association between left atrium enlargement and intradialytic hypotension: role of diastolic dysfunction in the hemodynamic complications during hemodialysis: CME," Echocardiography, vol. 26, no. 7, pp. 767-771, 2009.
31. G. Tripepi, F. Mattace-Raso, F. Mallamaci et al., "Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease," Hypertension, vol. 54, no. 4, pp. 818-824, 2009.
32. G. Tripepi, F. A. Benedetto, F. Mallamaci, R. Tripepi, L. Malatino, and C. Zoccali, "Left atrial volume in end-stage renal disease: a prospective cohort study," Journal of Hypertension, vol. 24, no. 6, pp. 1173-1180, 2006.
33. G. Tripepi, F. A. Benedetto, F. Mallamaci, R. Tripepi, L. Malatino, and C. Zoccali, "Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study," Journal of the American Society of Nephrology, vol. 18, no. 4, pp. 1316-1322, 2007.
34. S. Genovesi, A. Vincenti, E. Rossi et al., "Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients," American Journal of Kidney Diseases, vol. 51, no. 2, pp. 255-262, 2008.
35. W. C. Winkelmayer, A. R. Patrick, J. Liu, M. A. Brookhart, and S. Setoguchi, "The increasing prevalence of atrial fibrillation among hemodialysis patients," Journal of the American Society of Nephrology, vol. 22, no. 2, pp. 349-357, 2011.
36. C.-T. Chao, V.-C. Wu, C.-F. Lai et al., "Advanced age affects the outcome-predictive power of RIFLE classification in geriatric patients with acute kidney injury," Kidney International, vol. 82, no. 8, pp. 920-927, 2012.
37. N. Bansal, D. Fan, C.-Y. Hsu, J.D. Ordonez, G.M. Marcus, and A. S. Go, "Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease," Circulation, vol. 127, no. 5, pp. 569-574, 2013.
38. C. Zoccali, F. Mallamaci, R. Maas et al., "Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients," Kidney International, vol. 62, no. 1, pp. 339-345, 2002.
39. M. A. Alpert, "Cardiac performance and morphology in endstage renal disease," The American Journal of the Medical Sciences, vol. 325, no. 4, pp. 168-178, 2003.
40. D. Levy, M.G. Larson, R. S. Vasan, W. B. Kannel, and K. K. L. Ho, "The progression fromhypertension to congestive heart failure," Journal of the AmericanMedical Association, vol. 275, no. 20, pp. 1557-1562, 1996.
41. G. M. London, A. P. Guerin, and S. J. Marchais, "Pathophysiology of left ventricular hypertrophy in dialysis patients," Blood Purification, vol. 12, no. 4-5, pp. 277-283, 1994.
42. C. W. Doering, J. E. Jalil, J. S. Janicki et al., "Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy," Cardiovascular Research, vol. 22, no. 10, pp. 686-695, 1988.
43. C. W. Chin, A. S. Shah, V. Vassiliou et al., "Left ventricular hypertrophy with strain and aortic stenosis," Circulation, 2014.
44. D. Bernardi, L. Bernini, G. Cini, S. Ghione, and I. Bonechi, "Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients," American Heart Journal, vol. 109, no. 3, pp. 539-545, 1985.
45. P. G. Camici, I. Olivotto, and O. E. Rimoldi, "The coronary circulation and blood flow in left ventricular hypertrophy," Journal of Molecular and Cellular Cardiology, vol. 52, no. 4, pp. 857-864, 2012.
46. D. Kozhevnikov, E. B. Caref, and N. El-Sherif, "Mechanisms of enhanced arrhythmogenicity of regional ischemia in the hypertrophied heart," Heart Rhythm, vol. 6, no. 4, pp. 522-527, 2009.
47. R. Wolk, "Arrhythmogenic mechanisms in left ventricular hypertrophy," Europace, vol. 2, no. 3, pp. 216-223, 2000.
48. J. Kolb, T. M. Kitzler, T. Tauber, N. Morris, F. Skrabal, and P. Kotanko, "Proto-dialytic cardiac function relates to intradialytic morbid events," Nephrology Dialysis Transplantation, vol. 26, no. 5, pp. 1645-1651, 2011.
49. J. O. Burton, H. J. Jefferies, N. M. Selby, and C. W. McIntyre, "Hemodialysis-induced cardiac injury: determinants and associated outcomes," Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 914-920, 2009.
50. M. Y. Zuidema and K. C. Dellsperger, "Myocardial stunning with hemodialysis: clinical challenges of the cardiorenal patient," Cardiorenal Medicine, vol. 2, pp. 125-133, 2012.
51. G. Graziani, S. Finazzi, R. Mangiarotti et al., "Different cardiovascular responses to hemodialysis-induced fluid depletion and blood pressure compliance," Journal of Nephrology, vol. 23, no. 1, pp. 55-61, 2010.
52. E. Ritz, "Left ventricular hypertrophy in renal disease: Beyond preload and afterload," Kidney International, vol. 75, no. 8, pp. 771-773, 2009.
53. H. Schunkert, J.-I. Sadoshima, T. Cornelius et al., "Angiotensin II-induced growth responses in isolated adult rat hearts: evidence for load-independent induction of cardiac protein synthesis by angiotensin II," Circulation Research, vol. 76, no. 3, pp. 489-497, 1995.
54. M. Tomita, D. Malhotra, S. Dheenan, J. I. Shapiro, W. L. Henrich, and T. J. Santoro, "A potential role for immune activation in hemodialysis hypotension," Renal Failure, vol. 23, no. 5, pp. 637-649, 2001.
55. T. Sakurabayashi, S. Miyazaki, Y. Yuasa et al., "L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis," Circulation Journal, vol. 72, no. 6, pp. 926-931, 2008.
56. P. Strózecki, A. Adamowicz, E. Nartowicz, G. Odrowąz- Sypniewska, Z. Włodarczyk, and J. Manitius, "Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients," Renal Failure, vol. 23, no. 1, pp. 115-126, 2001.
57. C.-T. Chao, C.-F. Lai, and J.-W. Huang, "Risk factors for herpes zoster reactivation in maintenance hemodialysis patients," European Journal of InternalMedicine, vol. 23, no. 8, pp. 711-715, 2012.
58. S. van der Zee, A. Thompson, R. Zimmerman et al., "Vasopressin administration facilitates fluid removal during hemodialysis," Kidney International, vol. 71, no. 4, pp. 318-324, 2007.
59. K. E. Lynch, H. I. Feldman, J. A. Berlin, J. Flory, C. G. Rowan, and S. M. Brunelli, "Effects of L-carnitine on dialysis-related hypotension and muscle cramps: a meta-analysis," American Journal of Kidney Diseases, vol. 52, no. 5, pp. 962-971, 2008.
60. Y. L. Zhou, H. L. Liu, X. F. Duan, Y. Yao, Y. Sun, and Q. Liu, "Impact of sodium and ultrafiltration profiling on haemodialysis-related hypotension," Nephrology Dialysis Transplantation, vol. 21, no. 11, pp. 3231-3237, 2006.
61. F. Locatelli, P. Altieri, S. Andrulli et al., "Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD," Journal of theAmerican Society of Nephrology, vol. 21, no. 10, pp. 1798-1807, 2010.
62. E. Mancini, E. Mambelli, M. Irpinia et al., "Prevention of dialysis hypotension episodes using fuzzy logic control system," Nephrology, Dialysis, andTransplantation, vol. 22, pp. 1420-1427, 2007.
63. C. Déziel, J. Bouchard, M. Zellweger, and F. Madore, "Impact of hemocontrol on hypertension, nursing interventions, and quality of life: a randomized, controlled trial," Clinical Journal of the American Society of Nephrology, vol. 2, no. 4, pp. 661-668, 2007.
64. N. M. Selby, S. H. Lambie, P. G. Camici, C. S. Baker, and C. W. McIntyre, "Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis," American Journal of Kidney Diseases, vol. 47, no. 5, pp. 830-841, 2006.